Loading...

NBIX NEUROCRINE BIOSCIENCES INC Management Changes 8-K Filing

NRCR

NBX

NEUROCRINE BIOSCIENCES INC

(NBIX)

2025 8-K

Acquisition Completed

Financial Results Announced

Neurocrine Merger Announcement

Q4 2025 Results

Management Change

Financial Results Update

Financial Statements

Appointing of Directors

Financial Statements

Management Change

Financial Results

License Agreement Update

Share Repurchase

Q3 Earnings Report

Leadership Transition

Positive Study Results

Financial Results for Q2 2024

Management Change

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Agreement with Zydus

Patent Litigation Settlement

Financial Results Announcement

Settlement of Patent Litiga...

Announcement of Study Results

Phase 3 Study Results

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

External Links:

On November 21, 2025, Neurocrine Biosciences extended Dr. Eiry W. Roberts' employment as Strategic Advisor for an additional year, following her transition to Chief Medical Officer on June 2, 2025.

AI Assistant

NEUROCRINE BIOSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.